HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ken-Ichi Okada Selected Research

Ken-Ichi Okada Research Topics

Disease

29Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 01/2012
19Neoplasms (Cancer)
01/2024 - 01/2008
13Adenocarcinoma
12/2022 - 02/2009
8Pancreatic Fistula (Pancreatic Fistulas)
01/2023 - 03/2014
4Hemorrhage
03/2022 - 03/2014
3Hepatocellular Carcinoma (Hepatoma)
12/2023 - 07/2018
3Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2021 - 01/2008
3Pain (Aches)
01/2021 - 04/2014
3Fatigue
01/2020 - 01/2017
2Disease Progression
01/2024 - 11/2023
2Lymphatic Metastasis
01/2022 - 03/2019
2Neoplasms, Cystic, Mucinous, and Serous
01/2021 - 02/2010
2Edema (Dropsy)
01/2018 - 04/2014
2Carcinoma (Carcinomatosis)
01/2017 - 02/2009
2Parkinson Disease (Parkinson's Disease)
01/2016 - 01/2015
1Pneumonia (Pneumonitis)
11/2023
1Esophageal Neoplasms (Esophageal Cancer)
11/2023
1Frailty
12/2022
1Acute Cholecystitis
03/2022
1Factor VII Deficiency (Hypoproconvertinemia)
03/2022
1Duodenal Neoplasms (Duodenal Cancer)
01/2022
1Turcot syndrome
05/2021
1Cysts
01/2021
1Cognitive Dysfunction
01/2021
1Cholangiocarcinoma
07/2020
1Microsatellite Instability
07/2020
1Pancreatitis
04/2020
1Acquired Immunodeficiency Syndrome (AIDS)
02/2020
1Ileus
01/2020
1Ascites
01/2020
1Chronic Disease (Chronic Diseases)
01/2020
1Margins of Excision
03/2019
1Cholangitis
02/2018
1Sensation Disorders
01/2018
1Pancreatic Ductal Carcinoma
01/2017
1Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
03/2015
1Compartment Syndromes
04/2014

Drug/Important Bio-Agent (IBA)

7GemcitabineFDA Link
01/2024 - 01/2017
6AntigensIBA
01/2024 - 01/2017
6CarbohydratesIBA
01/2024 - 01/2017
6130-nm albumin-bound paclitaxelIBA
01/2024 - 01/2017
3Indicators and Reagents (Reagents)IBA
02/2010 - 02/2009
2Circulating Tumor DNAIBA
01/2024 - 03/2022
2PlasticsIBA
11/2021 - 01/2020
2Carcinoembryonic AntigenIBA
01/2021 - 01/2017
2folfirinoxIBA
01/2019 - 10/2016
1Histone MethyltransferasesIBA
12/2023
1N-acetyltalosaminuronic acid (NAT)IBA
11/2023
1AmylasesFDA Link
01/2023
1Biomarkers (Surrogate Marker)IBA
03/2022
1Factor VII (Proconvertin)IBA
03/2022
1recombinant FVIIa (rFVIIa)FDA Link
03/2022
1Factor VIIa (Activated Factor VII)IBA
03/2022
1Immune Checkpoint InhibitorsIBA
05/2021
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1pembrolizumabIBA
07/2020
1CytokinesIBA
01/2020
1ninjin'yoeitoIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
09/2018
1VaccinesIBA
01/2017
1EpitopesIBA
01/2017
1Peptides (Polypeptides)IBA
01/2017
1Tumor Biomarkers (Tumor Markers)IBA
01/2017
1OCV-C01IBA
01/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2017
1Therapeutic UsesIBA
01/2016
1Levodopa (L Dopa)FDA LinkGeneric
01/2015
1Analgesics (Analgesic Drugs)IBA
04/2014
1Small Interfering RNA (siRNA)IBA
04/2012
1MesothelinIBA
04/2012
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2012
1Hematoxylin (Haematoxylon)IBA
02/2010
1Eosine Yellowish-(YS) (Eosin)IBA
02/2010

Therapy/Procedure

17Pancreatectomy
05/2024 - 03/2014
11Neoadjuvant Therapy
12/2023 - 10/2016
11Pancreaticoduodenectomy
01/2023 - 01/2015
9Therapeutics
11/2023 - 11/2016
5Drug Therapy (Chemotherapy)
01/2024 - 01/2018
4Adjuvant Chemotherapy
12/2022 - 01/2020
3Stents
11/2021 - 02/2018
2Self Expandable Metallic Stents
11/2021 - 01/2020
2Pancreaticojejunostomy
01/2019 - 01/2016
2Operative Time
12/2017 - 01/2017
1Radiotherapy
11/2023
1Exercise Therapy (Therapy, Exercise)
12/2022
1Laparoscopic Cholecystectomy
03/2022
1Perioperative Period
03/2022
1Operative Surgical Procedures
01/2022
1Lymph Node Excision (Lymph Node Dissection)
10/2021
1Immunotherapy
05/2021
1Hepatectomy
03/2021
1Transcranial Magnetic Stimulation
01/2021
1Endoscopic Sphincterotomy
04/2020
1Preoperative Exercise
01/2020
1Sutures (Suture)
01/2019
1Ligation
11/2018
1Radiofrequency Ablation
07/2018
1Duration of Therapy
10/2016
1Deep Brain Stimulation
01/2016
1Roux-en-Y Anastomosis (Anastomosis, Roux en Y)
03/2014